Heroin assisted treatmentBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b4545 (Published 06 November 2009) Cite this as: BMJ 2009;339:b4545
- Wim van den Brink, professor of psychiatry and addiction
- 1Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands, PO Box 22660, 1100 DD Amsterdam, Netherlands
In September 2009, preliminary results were reported from the British Randomised Injectable Opiate Treatment Trial (RIOTT) on supervised heroin assisted treatment for patients who are dependent on heroin but do not respond to conventional methadone substitution treatment.1 One hundred and twenty seven patients were randomised to six months of supervised injectable heroin, supervised injectable methadone, or optimised oral methadone. Improvement was seen in the primary outcome measure of reduced use or abstinence from “street” heroin in all treatment groups, but the greatest effect was seen in people who received supervised injectable heroin—three quarters remained abstinent from illegal heroin, and number of days with criminal …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial